Update on antiviral DNA vaccine research (1998-2000).
DNA vaccines can induce protective cellular and humoral immune responses and have therefore been used during the last decade to develop vaccines against a variety of different pathogens. Because current antiviral vaccines predominantly generate humoral immunity, DNA immunization may be especially useful to provide long-term protection against viral diseases that also require cellular immunity (e.g. HIV). A significant number of articles published in the field of DNA vaccines are dealing with viral diseases, reflecting the need for better and alternative vaccination strategies against viruses. The success of DNA immunization depends on a variety of parameters (e.g. type of antigen, method of application and usage of adjuvants). Therefore, different strategies have been explored to modulate the induced immune response with respect to the requirements necessary to protect against a specific pathogen (e.g. induction of mucosal or cell-mediated immunity). The following article provides an update on different aspects of antiviral DNA vaccine research that have previously been reviewed by others.
Institute of Medical Virology, University of Zurich, Switzerland.
J
J
Schultz
G
G
Dollenmaier
K
K
Mölling
D000818:Animals; D000956:Antigens, Viral / Q000235:genetics / Q000276:immunology; D006801:Humans; D012106:Research; D019444:Vaccines, DNA; D014765:Viral Vaccines / Q000235:genetics* / Q000276:immunology; D014777:Virus Diseases / Q000517:prevention & control
D000956:Antigens, Viral; D019444:Vaccines, DNA; D014765:Viral Vaccines